National HealthCare Corporation research snapshot
NHC AI stock analysis reads National HealthCare Corporation as a 50-year operator of skilled nursing, assisted living, home care, and hospice facilities across the southeastern United States. At the July 12, 2026 data cutoff, NHC traded near $214.18 with a verified market capitalization of approximately $3.35 billion following a major portfolio transaction acquiring 35 facilities from National Health Investors (NHI) for $560 million. This page presents scenario ranges, technical levels, and source-verified data, not a certain stock price prediction, and is for informational use only.
Current price
$214.18
Market cap
$3.35 billion
AI score
65 / 100
Rating
Long-term senior care operator, post-acquisition integration watch
Trend status
Near 52-week high after transformative NHI facility acquisition
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | NHC operates 80 skilled nursing centers, 26 assisted living communities, 9 independent living communities, 30 hospice agencies, and 34 home care agencies across 11 states. Revenue is recurring and partially protected by demographic demand from aging baby boomers, but skilled nursing faces labor cost and reimbursement pressure. | Medium |
| Moat | Moat is moderate and based on local market presence, licensed bed capacity, relationships with hospitals and referral sources, and 50 years of operating history in the southeastern US. Real estate ownership provides an asset-backed buffer. However, barriers to entry are not insurmountable and large competitors like Ensign (ENSG) have more scale. | Medium |
| Management | Management under CEO Stephen Fowler Flatt has demonstrated long-term strategic thinking through the acquisition of 35 NHI facilities and a separate $50.5M facility purchase. The ability to integrate these assets accretively and manage skilled nursing labor costs will determine near-term performance. | Medium |
| Financial trend | Revenue has grown steadily from ~$1.4B to $1.53B TTM. Net income has been positive and growing. The balance sheet is conservative with low debt/equity of 3.58% and $258M cash. Levered free cash flow of $118.57M provides flexibility. | Medium-high |
| Valuation | At $214.18, NHC trades at 27.18x TTM P/E, 3.03x book value, and 2.02x EV/revenue. EV/EBITDA of 14.46x is moderate for healthcare services. The 3-scenario model suggests the stock is pricing in above-base growth expectations. | Medium |
| Technical trend | NHC has rallied strongly from a 52-week low near $93.54 to the $214 area, approaching the 52-week high near $220.86. The stock shows strong upward momentum with YTD return of ~57%, but is near resistance levels. | Medium |
| Risk level | Main risks include NHI portfolio integration execution, skilled nursing labor shortages and wage inflation, Medicaid/Medicare reimbursement rate changes, regulatory compliance, and interest rate sensitivity for the real estate-backed business model. | Medium-high |
| AI confidence | High for descriptive and verifiable facts, medium for forward integration scenarios and combined financial estimates due to the recent NHI acquisition closing. | Medium-high data confidence |
| Investment certainty | Medium certainty. The page frames scenarios and monitoring rules, not a buy or sell instruction. The NHI acquisition is transformative and its success will determine whether the current valuation is justified. | Medium |
NHC AI stock forecast
The NHC AI stock forecast uses scenario math around the $214.18 quote and current earnings power. The three-year framework produced a bearish area near $125, a base area near $193, and a bullish area near $277 if the stated earnings growth and valuation assumptions hold.
$240 to $280
More likely if the NHI portfolio acquisition integrates smoothly and delivers margin expansion, skilled nursing occupancy rates continue recovering, labor cost pressures ease, and the market re-rates the stock to 22-25x normalized EPS above $10.00.
$175 to $210
More likely if NHC maintains current earnings growth of 5-7%, the NHI acquisition is modestly accretive, senior care occupancy stabilizes, and the stock trades near 18-20x forward earnings.
$115 to $140
More likely if the NHI acquisition faces integration difficulties, skilled nursing labor costs escalate, Medicaid/Medicare reimbursement rates are cut, or a recession reduces elective healthcare procedures and private-pay occupancy.
NHC AI technical analysis
NHC AI technical analysis shows a strong upward trend from the 52-week low of $93.54, but the stock is approaching the all-time high zone near $220.86 as of the July 12, 2026 data cutoff. Volume and momentum trends should be monitored for signs of exhaustion near the high end of the historical range.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $214.18 | Yahoo Finance quote snapshot on July 9, 2026. Google Finance shows $210.38 on July 10 close. |
| Near support | $195 to $200 | The area around $195 to $200 represents a prior consolidation zone after the May 2026 rally and may act as near-term support. |
| Deeper support | $170 to $180 area | The $170 to $180 area corresponds to the April 2026 trading range and the 50-day moving average estimate. |
| Main resistance | $220 to $225 | The 52-week high near $220.86 is the main overhead resistance. Google Finance and Yahoo both show the high between $220 and $221. |
| Breakout target | $245 to $260 | If NHC clears the 52-week high on volume, the next technical target zone would be around $245 to $260 based on prior range extension patterns. |
| Momentum | RSI likely elevated | After the sustained rally from $93.54, RSI is likely in the 65-75 range, approaching overbought territory. |
| Volume | Average volume near 131,000 shares | Yahoo Finance shows average volume of 131,218 shares. Google Finance shows 151,440. Low volume means price moves may be amplified. |
| Volatility | About 3% below the 52-week high | Recent snapshots show NHC roughly 3% below its 52-week high, suggesting potential for either a breakout or a resistance rejection. |
| Invalidation | Close below $170 | A decisive close below the $170 area would weaken the uptrend and suggest a return to the lower end of the multi-month range. |
NHC AI trading strategy
The NHC AI trading strategy is a rules-based research framework for monitoring a senior care operator undergoing a transformative portfolio expansion. It is not personal advice and should be paired with fresh filings, price data, position sizing, and risk limits.
Watch for NHC to clear the $220 to $225 resistance zone on above-average volume and hold above it. A sustained move toward the $245-$260 area would require continued integration progress on the NHI facilities, stable occupancy rates, and steady reimbursement trends.
A close back below $200 or a failed breakout after the next earnings update should invalidate the near-term trend-following setup.
If NHC pulls back toward the $195 to $200 support zone without a negative fundamental catalyst, compare the pullback with industry occupancy data, labor cost trends, and management guidance before assuming support is durable.
Do not average down without a maximum loss rule because healthcare services stocks can gap on reimbursement policy, regulatory, or labor market news.
Track NHI facility integration progress and margin contribution, skilled nursing occupancy rates, labor cost per patient day, Medicaid/Medicare reimbursement rate changes, free cash flow generation, balance sheet leverage after the acquisition financing, and insider trading patterns.
Reduce confidence if NHI integration shows cost overruns, occupancy declines, FCF conversion deteriorates, insider selling accelerates, or debt increases significantly from the acquisition financing.
Investment research summary
NHC operates skilled nursing facilities, assisted living, independent living, home care, and hospice services primarily in the southeastern United States. Customers (patients and their families) pay for long-term and post-acute care, with revenue coming from Medicare, Medicaid, private insurance, and private-pay sources.
The moat is moderate and locally grounded. NHCs 50-year operating history, licensed bed capacity, real estate assets, and relationships with hospital discharge planners and referral sources create local competitive positions. However, the senior care industry is fragmented and competitors like Ensign (ENSG) and Brookdale (BKD) compete for the same patients and labor.
The thesis fails if the NHI facility acquisition integration proves more expensive or slower than expected, the expanded portfolio cannot sustain historical occupancy and margin levels, labor shortages force wage inflation above reimbursement growth, or Medicare/Medicaid policy changes reduce reimbursement rates significantly.
CEO Stephen Fowler Flatt leads a management team that has operated NHC through five decades. The strategic decision to acquire 35 NHI facilities for $560 million represents a major portfolio transformation. Capital allocation should be assessed by whether the acquired facilities are integrated accretively and whether the combined entity generates higher returns on invested capital.
NHC operates in the senior care industry, which benefits from long-term demographic tailwinds as the US population ages. The 65+ population is expected to grow significantly over the next decade, driving demand for skilled nursing, assisted living, and home care services. However, labor shortages and reimbursement pressure are structural challenges.
At 27x TTM P/E, 14.5x EV/EBITDA, and 3.0x book value, NHC trades above its historical average multiple. The three-scenario model suggests the current price embeds base-to-bullish assumptions about the NHI acquisition and operating environment. Margin of safety would improve if price revisited the $175-$190 zone while the fundamental thesis stays intact.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| NHC price | $214.18 | Yahoo Finance quote snapshot | July 12, 2026 |
| Market capitalization | $3.35 billion, verified as $214.18 x 15.62 million shares (0.01% deviation) | financial_rigor.py market cap verification | July 12, 2026 |
| TTM revenue | Approximately $1.53 billion based on Yahoo Finance and Google Finance quarterly data | Yahoo Finance key statistics | July 12, 2026 |
| TTM net income | Approximately $123.67 million | Yahoo Finance key statistics | July 12, 2026 |
| Cash and debt | $258.35 million cash, enterprise value $3.09 billion, debt/equity 3.58% | Yahoo Finance key statistics | July 12, 2026 |
| Recent quarterly revenue | Q1 2026: $381.82M, Q4 2025: $386.51M, Q3 2025: $382.66M, Q2 2025: $374.91M | Google Finance quarterly financials | July 12, 2026 |
| Recent quarterly net income | Q1 2026: $35.86M, Q4 2025: $24.85M, Q3 2025: $39.24M, Q2 2025: $23.72M | Google Finance quarterly financials | July 12, 2026 |
| 52-week range | $93.54 to $220.86 | Yahoo Finance quote data | July 12, 2026 |
| Analyst rating | BUY (Argus Research), price targets from $211 to $238 in July 2026 | Yahoo Finance research reports | July 12, 2026 |
| Shares outstanding | 15.62 million | Google Finance statistics | July 12, 2026 |
| Dividend | $2.59 annual (1.22% yield), quarterly $0.67 | Yahoo Finance dividend data | July 12, 2026 |
| NHI facility acquisition | Completed acquisition of 35 facilities from National Health Investors for $560 million in July 2026 | Yahoo Finance news | July 12, 2026 |
This page is an informational research tool only and is not investment advice, financial advice, or a recommendation to buy or sell NHC stock. Forecast scenarios are based on available public data, technical snapshots, and stated assumptions as of the data cutoff date and may be wrong. Always verify current filings, prices, risks, and personal suitability before making financial decisions.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
